Avoro Capital Advisors LLC Adverum Biotechnologies, Inc. Transaction History

Avoro Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $5.63 Million - $9.31 Million	-6,950,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $3.53 Million - $11.1 Million	-1,050,000 Reduced 13.13%	6,950,000 $24.3 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $4.27 Million - $8.98 Million	415,000 Added 5.47%	8,000,000 $82.4 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $3.71 Million - $11.2 Million	435,000 Added 6.08%	7,585,000 $158 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $15.2 Million - $31 Million	1,900,000 Added 36.19%	7,150,000 $69.9 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $5.12 Million - $12.2 Million	1,000,000 Added 23.53%	5,250,000 $60.5 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $3.93 Million - $11.9 Million	750,000 Added 21.43%	4,250,000 $23.2 Million
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $17.9 Million - $41.6 Million	3,500,000 New	3,500,000 $41.6 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.